These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35935266)

  • 1. Novel computational models offer alternatives to animal testing for assessing eye irritation and corrosion potential of chemicals.
    Silva AC; Borba JVVB; Alves VM; Hall SUS; Furnham N; Kleinstreuer N; Muratov E; Tropsha A; Andrade CH
    Artif Intell Life Sci; 2021 Dec; 1():. PubMed ID: 35935266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STopTox: An
    Borba JVB; Alves VM; Braga RC; Korn DR; Overdahl K; Silva AC; Hall SUS; Overdahl E; Kleinstreuer N; Strickland J; Allen D; Andrade CH; Muratov EN; Tropsha A
    Environ Health Perspect; 2022 Feb; 130(2):27012. PubMed ID: 35192406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the chemical-induced eye injury using a weight-of-evidence (WoE) battery of 21 artificial neural network (ANN) c-QSAR models (QSAR-21): part I: irritation potential.
    Verma RP; Matthews EJ
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):318-30. PubMed ID: 25497990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine-learning based prediction models for assessing skin irritation and corrosion potential of liquid chemicals using physicochemical properties by XGBoost.
    Kang Y; Kim MG; Lim KM
    Toxicol Res; 2023 Apr; 39(2):295-305. PubMed ID: 37008690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a tiered in vitro testing strategy for assessing the ocular and dermal irritation/corrosion potential of pharmaceutical compounds for worker safety.
    Graham JC; Wilt N; Costin GE; Villano C; Bader J; Krawiec L; Sly E; Gould J
    Cutan Ocul Toxicol; 2018 Dec; 37(4):380-390. PubMed ID: 30035615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the chemical-induced eye injury using a Weight-of-Evidence (WoE) battery of 21 artificial neural network (ANN) c-QSAR models (QSAR-21): part II: corrosion potential.
    Verma RP; Matthews EJ
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):331-6. PubMed ID: 25510831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-Descriptor Read Across (MuDRA): A Simple and Transparent Approach for Developing Accurate Quantitative Structure-Activity Relationship Models.
    Alves VM; Golbraikh A; Capuzzi SJ; Liu K; Lam WI; Korn DR; Pozefsky D; Andrade CH; Muratov EN; Tropsha A
    J Chem Inf Model; 2018 Jun; 58(6):1214-1223. PubMed ID: 29809005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PreS/MD: Predictor of Sensitization Hazard for Chemical Substances Released From Medical Devices.
    Alves VM; Borba JVB; Braga RC; Korn DR; Kleinstreuer N; Causey K; Tropsha A; Rua D; Muratov EN
    Toxicol Sci; 2022 Sep; 189(2):250-259. PubMed ID: 35916740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixtures-Inclusive
    Sedykh A; Choksi NY; Allen DG; Casey WM; Shah R; Kleinstreuer NC
    Chem Res Toxicol; 2022 Jun; 35(6):992-1000. PubMed ID: 35549170
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Kang Y; Jeong B; Lim DH; Lee D; Lim KM
    J Toxicol Environ Health A; 2021 Dec; 84(23):960-972. PubMed ID: 34328061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A three-tier QSAR modeling strategy for estimating eye irritation potential of diverse chemicals in rabbit for regulatory purposes.
    Basant N; Gupta S; Singh KP
    Regul Toxicol Pharmacol; 2016 Jun; 77():282-91. PubMed ID: 27018829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative structure-Activity relationships for skin irritation and corrosivity of neutral and electrophilic organic chemicals.
    Barratt MD
    Toxicol In Vitro; 1996 Jun; 10(3):247-56. PubMed ID: 20650203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Draize eye irritation testing and its prediction by mining publicly available 2008-2014 REACH data.
    Luechtefeld T; Maertens A; Russo DP; Rovida C; Zhu H; Hartung T
    ALTEX; 2016; 33(2):123-34. PubMed ID: 26863293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of existing (Q)SAR models for skin and eye irritation and corrosion to use for REACH registration.
    Verheyen GR; Braeken E; Van Deun K; Van Miert S
    Toxicol Lett; 2017 Jan; 265():47-52. PubMed ID: 27865849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of SARs for the prediction of eye irritation/corrosion potential: structural inclusion rules in the BfR decision support system.
    Tsakovska I; Saliner AG; Netzeva T; Pavan M; Worth AP
    SAR QSAR Environ Res; 2007; 18(3-4):221-35. PubMed ID: 17514567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a decision support system for the introduction of alternative methods into local irritancy/corrosivity testing strategies. Creation of fundamental rules for a decision support system.
    Gerner I; Zinke S; Graetschel G; Schlede E
    Altern Lab Anim; 2000; 28(5):665-98. PubMed ID: 11091765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of eye irritation from organic chemicals using membrane-interaction QSAR analysis.
    Kulkarni A; Hopfinger AJ; Osborne R; Bruner LH; Thompson ED
    Toxicol Sci; 2001 Feb; 59(2):335-45. PubMed ID: 11158727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human-relevant approaches to assess eye corrosion/irritation potential of agrochemical formulations.
    Clippinger AJ; Raabe HA; Allen DG; Choksi NY; van der Zalm AJ; Kleinstreuer NC; Barroso J; Lowit AB
    Cutan Ocul Toxicol; 2021 Jun; 40(2):145-167. PubMed ID: 33830843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical appraisal of alternative irritation models: three decades of testing ophthalmic pharmaceuticals.
    Abdelkader H; Pierscionek B; Carew M; Wu Z; Alany RG
    Br Med Bull; 2015 Mar; 113(1):59-71. PubMed ID: 25686845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simplified index to quantify the irritation/corrosion potential of chemicals - Part II: Eye.
    Charmeau-Genevois C; Sarang S; Perea M; Mayer N; Eadsforth C; Austin T; Thomas P
    Regul Toxicol Pharmacol; 2021 Jul; 123():104935. PubMed ID: 33901590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.